Jesse Hinckley, MD, PhD
Assistant Clinical Professor, Psychiatry-Substance Dependence

Photo
Download CV
Medical School:
  • MD, University of Colorado Denver School of Medicine (2015)
Graduate School :
  • PhD, University of Colorado Health Sciences Center (2015)
Undergraduate School:
  • BSc (Hons), Brigham Young University (UT) (2005)
Internship:
  • University of Colorado (University Hospital) Program (2016)
Residency:
  • University of Colorado (University Hospital) Program, Psychiatry (2018)
Fellowships:
  • University of Colorado (Children's Hospital Colorado) Program, Child and Adolescent Psychiatry (2020)
Languages: English
Department: Psychiatry-Substance Dependence

Professional Titles

  • Assistant Professor
  • Associate Medical Director, Clinical Decision Unit-2 (Psychiatric Emergency Services)
  • Director, Adolescent Psychiatric Services, Addiction Research and Treatment Services
  • Co-Director, Addiction Biology Lab

Recognition & Awards

  • Colorado Psychiatric Society Resident Advocacy Award, Colorado Psychiatric Society (2020)
  • Randall Ross, MD, Clinical Scientist Award, University of Colorado Department of Psychiatry (2018)
  • National Institute on Drug Abuse-American Academy of Child and Adolescent Psychiatry Resident Training Award in Substance Use Disorders, American Academy of Child and Adolescent Psychiatry (2018)

Publications

  • Molinero K, Hinckley JD. Adolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders. Child Adolesc Psychiatr Clin N Am. 2023 Jan;32(1):57-68. PubMed PMID: 36410906
  • Adams ZW, Marriott BR, Hulvershorn LA, Hinckley J. Treatment of Adolescent Cannabis Use Disorders. Child Adolesc Psychiatr Clin N Am. 2023 Jan;32(1):141-155. PubMed PMID: 36410901
  • Hinckley JD, Saba L, Raymond K, Bartels K, Klawitter J, Christians U, Hopfer C. An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses. Cannabis Cannabinoid Res. 2022 Feb;7(1):65-77. PubMed PMID: 33998853
  • Bhatia D, Hinckley J, Mikulich S, Sakai J. Cannabis Legalization and Adolescent Use of Electronic Vapor Products, Cannabis, and Cigarettes. J Addict Med. 2022 Jan-Feb 01;16(1):e16-e22. PubMed PMID: 35120066
  • Jesse D. Hinckley, Devika Bhatia, Jarrod Ellingson, Karla Molinero, and Christian Hopfer. The impact of recreational cannabis legalization on youth: The Colorado experience. European Child & Adolescent Psychiatry. 2022 April 15. https://doi.org/10.1007/s00787-022-01981-0. (PMID: 35428897)
  • Hinckley JD, Danielson CK. Elucidating the Neurobiologic Etiology of Comorbid PTSD and Substance Use Disorders. Brain Sci. 2022 Aug 31;12(9). PubMed PMID: 36138902
  • Hinckley J, Bhatia D, Ellingson J, Molinero K, Hopfer C. The impact of recreational cannabis legalization on youth: the Colorado experience. Eur Child Adolesc Psychiatry. 2022 Apr 15. [Epub ahead of print] PubMed PMID: 35428897
  • Bhatia D, Hinckley J, Mikulich S, Sakai J. Cannabis Legalization and Adolescent Use of Electronic Vapor Products, Cannabis, and Cigarettes. J Addict Med. 2022 Jan-Feb 01;16(1):e16-e22. PubMed PMID: 35120066
  • Hinckley JD, Saba L, Raymond K, Bartels K, Klawitter J, Christians U, Hopfer C. An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses. Cannabis Cannabinoid Res. 2022 Feb;7(1):65-77. PubMed PMID: 33998853
  • Winters DE, Brandon-Friedman R, Yepes G, Hinckley JD. Systematic review and meta-analysis of socio-cognitive and socio-affective processes association with adolescent substance use. Drug Alcohol Depend. 2021 Feb 1;219:108479. PubMed PMID: 33444900
  • Devika Bhatia, Jesse D. Hinckley, Susan Mikulich-Gilbertson, Joseph Sakai. Cannabis legalization and adolescent electronic vapor product, cannabis, and cigarette use. Journal of Addiction Medicine. 2021 April 23. https:// doi.org/10.1097/ADM.0000000000000831.
  • Jesse D. Hinckley and Christian Hopfer. Marijuana legalization in Colorado: increasing potency, changing risk perceptions, and emerging public health concerns. Adolescent Psychiatry. 2021 August 21. https://dio.org/10.2174/2210676611666210616163340.
  • Jarrod Ellingson, Jesse D. Hinckley, Megan Ross, Joseph Schact, Cinnamon Bidwell, Angela Bryan, Christian Hopfer, Paula Riggs, and Kent Hutchison. The Neurocognitive Effects of Cannabis Across the Lifespan. Current Behavioral Neuroscience Report. 2021 November 15. https://doi.org/10.1007/s40473-021-00244-7.
  • Ellingson JM, Hinckley JD, Ross JM, Schacht JP, Bidwell LC, Bryan AD, Hopfer CJ, Riggs P, Hutchison KE. The Neurocognitive Effects of Cannabis Across the Lifespan. Curr Behav Neurosci Rep. 2021 Dec;8(4):124-133. PubMed PMID: 35979200
  • Winters DE, Brandon-Friedman R, Yepes G, Hinckley JD. Systematic review and meta-analysis of socio-cognitive and socio-affective processes association with adolescent substance use. Drug Alcohol Depend. 2021 Feb 1;219:108479. PubMed PMID: 33444900
  • Hinckley JD, Riggs P. Integrated Treatment of Adolescents with Co-occurring Depression and Substance Use Disorder. Child Adolesc Psychiatr Clin N Am. 2019 Jul;28(3):461-472. PubMed PMID: 31076120
View All (16 Total) View Less

Practice Locations

UCHealth Emergency Care - Anschutz Medical Campus (Hospital-based)
12505 E. 16th Ave
Aurora, CO 80045
720-848-9111

ARTS: Synergy Adolescent Services
3680 W Princeton Cir
Denver, CO 80236
303-934-1008

Department of Psychiatry - Faculty and Staff Mental Health
1890 N Revere Ct
Anschutz Health Sciences Bldg, Suite 5242
Aurora, CO 80045
303-724-4987

Hospital Affiliation
  • University of Colorado Hospital
  • Children's Hospital Colorado
  • Denver Health Medical Center

Specialty Information

Specialties
  • Psychiatry, Board Certification
  • Child and Adolescent Psychiatry, Board Certification (2020)
  • Risk Reduction Family Therapy (RRFT), Specialized Training (2022)
  • Tobacco Treatment Specialist, Certificate (2020)
  • Encompass: Motivational Enhancement Therapy, Cognitive Behavioral Therapy, and Contingency Management for Adolescents and Young Adults, Specialized Training (2019)
  • DEA X-Waiver for medications for opioid use disorders, License (2018)
Conditions & Treatments
  • Mental Health and Behavior
  • Mental Health and Behavior - Anxiety
  • Mental Health and Behavior - Attention Deficit Disorder with Hyperactivity
  • Mental Health and Behavior - Bipolar Disorder
  • Mental Health and Behavior - Depression
  • Mental Health and Behavior - Panic Disorder
  • Mental Health and Behavior - Post-Traumatic Stress Disorder
  • Mental Health and Behavior - Stress
  • Substance Abuse
  • Substance Abuse - Alcoholism
  • Substance Abuse - Drug Abuse
  • Substance Abuse - Smoking Cessation
Clinical Interests
Adolescent Substance Treatment and Prevention Management of co-occurring mental health and substance use disorders in youth Medication management for opioid use disorder

General Information

Medical Schools:
  • MD, University of Colorado Denver School of Medicine (2015)
Graduate Schools:
  • PhD, University of Colorado Health Sciences Center (2015)
Undergraduate Schools:
  • BSc (Hons), Brigham Young University (UT) (2005)
Internships:
  • University of Colorado (University Hospital) Program (2016)
Residency Programs:
  • University of Colorado (University Hospital) Program, Psychiatry (2018)
Fellowships:
  • University of Colorado (Children's Hospital Colorado) Program, Child and Adolescent Psychiatry (2020)
Download CV
Languages: English
Department: Psychiatry-Substance Dependence
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;